HIM
ELV icon

Hanlon Investment Management’s Elevance Health ELV Stock Holding History

Hanlon Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,714
Closed -$2.6M – 49
2017
Q1 		$2.6M Buy
+15,714
New +$2.5M 0.33% 65

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hanlon Investment Management's ELV Position: Q2 2017 in Review

Hanlon Investment Management sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 15,714 shares — an estimated $2.6M sold.

Hanlon Investment Management first reported a position in ELV in Q1 2017 and held it in 1 quarter. The position peaked at $2.6M in Q1 2017. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Hanlon Investment Management reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
  • Hanlon Investment Management sold 15,714 Elevance Health shares in Q2 2017, an estimated $2.6M.
  • Hanlon Investment Management first reported a position in Elevance Health in Q1 2017 and held it in 1 quarter.
  • Hanlon Investment Management's Elevance Health position peaked at $2.6M in Q1 2017.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Hanlon Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.